Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacological evaluation of the development candidate].

T Nagao1

  • 1Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan.

Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|March 30, 1999
PubMed
Summary

Selecting the right drug candidate early in preclinical development is crucial for efficient drug discovery. Pharmacological evaluation, including in vivo studies, ensures drug safety and efficacy for clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of warfarin-induced hair loss with ubidecarenone.

Lancet (London, England)·1995
Same author

Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan.

Community dental health·1995
Same author

Inhibition of acetylcholinesterase modulates the autoregulation of cerebral blood flow and attenuates ischemic brain metabolism in hypertensive rats.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·1995
Same author

Platelet activation is not involved in acceleration of the coagulation system in acute cardioembolic stroke with nonvalvular atrial fibrillation.

Stroke·1995
Same author

Differential effects of selective beta 1-agonist stimulation on epi- and endocardial oxygen tension in anesthetized dogs.

Biological & pharmaceutical bulletin·1995
Same author

Effect of DP-1904, a thromboxane A2 synthase inhibitor, administered from the autologous phase on crescentic-type anti-GBM nephritis in rats.

Japanese journal of pharmacology·1995

Area of Science:

  • Pharmacology
  • Drug Discovery
  • Pharmaceutical Development

Context:

  • International use of Japanese-developed pharmaceuticals is increasing.
  • The preclinical phase is a critical stage in the drug development lifecycle.
  • Pharmacologists play a key role in identifying and evaluating potential drug compounds.

Purpose:

  • To highlight the importance of rigorous pharmacological evaluation in preclinical drug development.
  • To emphasize the role of pharmacologists in selecting viable drug candidates.
  • To underscore the necessity of in vivo studies for assessing drug safety and efficacy.

Summary:

  • The preclinical phase is critical for selecting drug candidates, involving pharmacologists in identifying and evaluating compounds.
  • In vivo animal studies are essential for assuring drug effectiveness and safety before clinical trials.

Related Experiment Videos

  • Understanding the drug's mechanism of action and its effect in disease states is vital, often based on known molecular targets.

    • Impact:

    • Streamlining the drug development process by saving time and resources.
    • Improving the success rate of drugs entering clinical trials.
    • Facilitating the international adoption of new pharmaceuticals through robust preclinical validation.